• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CSL

CSL LIMITED - Corporate Spotlight

0.61% ! $267.92
Market Cap $129.7B  !

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$267.92
Change
-1.640(0.61%)
Mkt cap ! $129.7B
Open High Low Value Volume
$269.56 $270.42 $267.15 $252.9M 957.6K

Buyers (Bids)

No. Vol. Price($)
1 879 $267.91
 

Sellers (Offers)

Price($) Vol. No.
$268.98 120 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.